logo

For the Inventor, By the Inventor

Danvers, MA, United States of America

Marine Polymer Technologies, Inc.

Calculating rank
USPTO Granted Patents = 39

% Expired Patents = 23.1



Trademarks = 13

Forward Citations = 773

Loading Chart...
Loading Chart...

8 inventors (with patents filed for the assignee):

goldMedal Sergio Finkielsztein (38 out of 44 patents)

silverMedal John N Vournakis (38 out of 45 patents)

bronzeMedal Ernest R Pariser (13 out of 15 patents)

4.  Mike Helton (12 out of 14 patents)

5.  Marco Finkielsztein (3 out of 3 patents)

6.  Giorgio Pietramaggiori (2 out of 2 patents)

7.  Dennis Paul Orgill (2 out of 13 patents)

8.  Sergio Finkielstein (1 out of 1 patent)

9.  Marina V Demcheva (0 patent)

10.  Ernst R Pariser (0 patent)

11.  Sergio Finkeilsztein (0 patent)

12.  Giorgio Pietramaggiori (0 patent)

13.  Dennis P Orgill (0 patent)

14.  Dennis P Orgill (0 patent)

15.  Giorgio Pietramaggiori (0 patent)


Core Competencies:
Poly-N-acetylglucosamine
Hemostatic Compositions
Wound Healing
Vascular Compression
Anti-Bacterial Applications
Cell Therapy
Biocompatible Polymers
Therapeutic Regimens
Polymer Materials
Vascular Access
Nanofibers

39 patents:

1. 10765698 - Treatment of disease with poly-N-acetylglucosamine nanofibers (2020-09-08),
2. 10561677 - Anti-bacterial applications of poly-N-acetylglucosamine nanofibers (2020-02-18),
3. 10383971 - Hemostatic compositions and therapeutic regimens (2019-08-20),
4. 10252040 - Application of polymeric materials to screens to facilitate hemostasis and wound healing (2019-04-09),
5. 10206938 - Anti-bacterial applications of poly-N-acetylglucosamine nanofibers (2019-02-19),
6. 10206683 - Methods and apparatus for a manual vascular compression device (2019-02-19),
7. 9867625 - Methods and apparatus for a manual radial artery compression device (2018-01-16),
8. 9642871 - Anti-bacterial applications of poly-N-acetylglucosamine nanofibers (2017-05-09),
9. 9320653 - Hemostatic compositions and uses therefor (2016-04-26),
10. 9198928 - Anti-bacterial applications of poly-N-acetylglucosamine nanofibers (2015-12-01),
11. 9139664 - Hemostatic compositions and therapeutic regimens (2015-09-22),
12. 9139663 - Hemostatic compositions and therapeutic regimens (2015-09-22),
13. 8992453 - Vascular access preservation in hemodialysis patients (2015-03-31),
14. 8871247 - Hemostatic compositions and therapeutic regimens (2014-10-28),
15. 8859528 - Compositions and methods for modulation of vascular structure and/or function (2014-10-14),
Company Overview
Marine Polymer Technologies, Inc. is a biotechnology company based in Danvers, Massachusetts, specializing in the development of innovative medical products derived from marine sources. The company focuses on creating advanced biomaterials and drug delivery systems, leveraging its expertise in polysaccharide chemistry. With a commitment to enhancing patient care, Marine Polymer Technologies aims to address unmet medical needs through its research in regenerative medicine and therapeutic applications.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

39 Patents

#5 in Danvers, MA

#515 in Massachusetts

#8,835 in US

#17,475 in the World

Danvers, MA (US)
Danvers, MA, United States of America

Marine Polymer Technologies, Inc.

Forward Citations = 773

8 inventors:

goldMedal Sergio Finkielsztein (38 out of 44 patents)

silverMedal John N Vournakis (38 out of 45 patents)

bronzeMedal Ernest R Pariser (13 out of 15 patents)

4.  Mike Helton (12 out of 14 patents)

5.  Marco Finkielsztein (3 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Marine Polymer Technologies, Inc.. Retrieved from https://idiyas.com/company/marine-polymer-technologies

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…